Lipase elevation without symptoms: the interpretation problem Writing it up because I had to work it out twice and would rather nobody else did.
Lipase elevation without symptoms — I have the observation and I do not trust my interpretation of it, so I am posting the observation and holding the interpretation back.
Numbers, method and the conditions under which they were collected are below. Interpret them however they warrant.
Thank you — that answers what I came here to find out.
Answering the question the opening post raises rather than the one it answers.
TSH and free hormones: TSH is a reasonable screening test but does not tell you about actual free hormone levels. If TSH is abnormal, free thyroid hormones confirm whether there is a real thyroid problem.
Adding a reference point for lipase elevation without symptoms. Mine is a single case, collected without controls, and I am posting the method alongside it so it can be discounted appropriately.
I would call the community position on lipase elevation without symptoms likely rather than established, and I would be comfortable defending that hedge.
Building on post #5 rather than restating it.
Repeat before acting is standard practice for an isolated abnormal result on most analytes, and it is standard for a reason.
Speaking for myself and not for anyone else who has posted here.
The honest answer on lipase elevation without symptoms is that it depends, and the useful part is the list of what it depends on. Four items, in rough order of how much they matter.
Most people get the first two right and then argue about the fourth.
Glycaemic markers integrate over different periods. A point glucose and a longer-term marker disagreeing is not a contradiction; it is two different questions.
I have separated what I observed from what I concluded, which does not always happen.
Time of day: some biomarkers vary across the day. Cortisol in the morning differs from cortisol in the evening. Comparing results from different times of day is comparing things that are not the same.
A single value outside interval: usually uninformative on a single draw. What makes a result interesting: a trend across multiple draws, a magnitude well beyond the interval, a pattern that coheres with other values, or symptoms that fit.
Happy to be corrected if someone holds better data than mine.
Adding the measurement that post #10 says would settle it.
Where the lipase elevation without symptoms reasoning breaks down for me is the step from the group result to the individual case. That step is almost never argued for.
A note on scope: what I am saying about lipase elevation without symptoms applies to the case in the first post and I would not extend it further without checking.
A trend needs at least three points to be a trend. Two points are a line and a line through noise is still a line.
Right — I had this wrong and I am glad to have read it before it mattered.
The arithmetic in post #14 is right; the assumption feeding it is the part to check.
Where a panel includes a calculated value, that value inherits the imprecision of everything it was calculated from and is usually reported without an interval.
That is the practical version. The rigorous version is longer and says the same thing.
Answering the question post #17 raises rather than the one it answers.
Liver enzyme changes during rapid weight loss are commonly reported and have several possible explanations, which is exactly why they need clinical interpretation rather than forum interpretation.
I would hold that lightly until someone with a larger sample weighs in.
Post #18 answers the question as asked. The question underneath it is different.
Lipase elevation without symptoms is worth one more sentence than it usually gets, and the sentence is the one about how the number was arrived at.
Trying to state the lipase elevation without symptoms position in a way that someone who disagrees would recognise as fair, because I do not think the version in this thread passes that test.
Repeat before acting is standard practice for an isolated abnormal result on most analytes, and it is standard for a reason.
Reporting the observation and leaving the explanation open deliberately.
Glycaemic markers integrate over different periods. A point glucose and a longer-term marker disagreeing is not a contradiction; it is two different questions.
A qualification I should have led with rather than closed on.
Lipid panel interpretation: total, LDL, HDL, triglycerides all on one panel. Reading them together is more informative than reading one value in isolation. An elevated triglyceride with low HDL is different from triglyceride elevation alone.
The failure mode on lipase elevation without symptoms is boring rather than dramatic. It is almost always the step everyone assumes was done correctly because it is too simple to get wrong.
| Topic | Participants | Replies | Views | Activity |
|---|---|---|---|---|
|
Micronutrient status when intake falls substantially — a second dataset
Micronutrient status when intake falls substantially — a second dataset Writing it up because I had to work it out twice and would rather nobody else did. Posting a small dataset on Micronutrient status. It…
|
+9 | 13 | 274 | 14mo |
|
Revisiting: How to bring a laboratory report to an appointment usefully
Revisiting: How to bring a laboratory report to an appointment usefully — setting out what I have, and where I think it stops being reliable. Asking about bring a laboratory directly, because I have read four…
|
+143 | 154 | 1.7k | 21mo |
|
HbA1c lag and what it can and cannot tell you at eight weeks
HbA1c lag and what it can and cannot tell you at eight weeks Writing it up because I had to work it out twice and would rather nobody else did. Something about hba1c lag does not reconcile and I would like a…
|
+14 | 18 | 2.6k | 14mo |
|
HbA1c lag and what it can and cannot tell you at eight weeks — one year on
Posting this under the heading it deserves: HbA1c lag and what it can and cannot tell you at eight weeks — one year on Everything below is what sits behind that. A methods question rather than a substantive…
|
+18 | 22 | 655 | 13h |
|
Liver enzymes drifting down and what that usually means
Liver enzymes drifting down and what that usually means — setting out what I have, and where I think it stops being reliable. A methods question rather than a substantive one, about liver enzymes drifting.…
|
+66 | 72 | 12k | 4mo |
| Topic | Participants | Replies | Views | Activity |
|---|---|---|---|---|
|
HbA1c lag and what it can and cannot tell you at eight weeks — one year on
Posting this under the heading it deserves: HbA1c lag and what it can and cannot tell you at eight weeks — one year on Everything below is what sits behind that. A methods question rather than a substantive…
|
+18 | 22 | 655 | 13h |
|
[2026 update] Lipid changes during rapid weight loss: the expected trajectory
Lipid changes during rapid weight loss: the expected trajectory Writing it up because I had to work it out twice and would rather nobody else did. Lipid changes during rapid weight keeps being re-asked here…
|
+51 | 56 | 7.1k | 17mo |
|
Second pass at: Fasting versus non-fasting and which tests care
On the subject in the title: Second pass at: Fasting versus non-fasting and which tests care Working notes rather than a conclusion. Posting a small dataset on Fasting versus non-fasting. It is mine, it is…
|
+20 | 25 | 21k | 3mo |
|
eGFR fluctuation and the creatinine denominator problem — the long version
eGFR fluctuation and the creatinine denominator problem — the long version — setting out what I have, and where I think it stops being reliable. A narrow question about egfr fluctuation, deliberately narrow,…
|
+43 | 47 | 17k | just now |
|
Which panel is worth repeating and which is worth ignoring — a second dataset
Asking directly, because I could not find a straight answer: Which panel is worth repeating and which is worth ignoring — a second dataset Posting a small dataset on panel. It is mine, it is uncontrolled, and…
|
+108 | 117 | 46k | 4mo |